BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20380096)

  • 41. Vaginal and cervical pH in bacterial vaginosis and cervicitis during pregnancy.
    Sagawa T; Negishi H; Kishida T; Yamada H; Fujimoto S
    Hokkaido Igaku Zasshi; 1995 Nov; 70(6):839-46. PubMed ID: 8582707
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utilisation of hydrogen peroxide in the treatment of recurrent bacterial vaginosis.
    Cardone A; Zarcone R; Borrelli A; Di Cunzolo A; Russo A; Tartaglia E
    Minerva Ginecol; 2003 Dec; 55(6):483-92. PubMed ID: 14676737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibiotics and bacterial vaginosis].
    Berrebi A
    Rev Fr Gynecol Obstet; 1993 Mar; 88(3 Pt 2):215-7. PubMed ID: 8484091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trial with praneem polyherbal cream in patients with abnormal vaginal discharge due to microbial infections.
    Mittal A; Kapur S; Garg S; Upadhyay SN; Suri S; Das SK; Gupta S; Talwar GP
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):190-1. PubMed ID: 7677686
    [No Abstract]   [Full Text] [Related]  

  • 45. [New alternatives in the treatment of bacterial vaginosis].
    Luis Arredondo J; Higuera F; Narcio ML; Casanova G; Beltrán M
    Ginecol Obstet Mex; 1994 Aug; 62():226-34. PubMed ID: 7959144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial.
    Paternoster DM; Tudor L; Milani M; Maggino T; Ambrosini A
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):198-201. PubMed ID: 15280147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Sucrose Gel for the treatment of bacterial vaginosis: a phase II clinical trial].
    Xiao BB; Wu C; Lin HX; Zhang D; Geng L; Wang HL; Yu FH; Zhu SN; Yao C; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):746-51. PubMed ID: 21170109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience].
    Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E
    Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative study of combined local treatment (sulfadimidine, metronidazole and nystatin) and the standard monotherapy in uncomplicated bacterial vaginosis].
    Milánkovits M; Baksay L; Plachy J
    Orv Hetil; 2002 Dec; 143(51):2835-40. PubMed ID: 12638310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in vaginal flora after 2% clindamycin vaginal cream in women at high risk of preterm birth.
    Lamont DF
    BJOG; 2003 Aug; 110(8):788-9. PubMed ID: 12892701
    [No Abstract]   [Full Text] [Related]  

  • 51. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2020 Sep; 109(12):1003-1004. PubMed ID: 32933399
    [No Abstract]   [Full Text] [Related]  

  • 52. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide.
    Harwell JI; Moench T; Mayer KH; Chapman S; Rodriguez I; Cu-Uvin S
    J Womens Health (Larchmt); 2003 Apr; 12(3):255-9. PubMed ID: 12804356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and acceptability of 6% cellulose sulfate vaginal gel applied four times per day for 14 days.
    Doh AS; Ngoh N; Roddy R; Lai JJ; Linton K; Mauck C
    Contraception; 2007 Sep; 76(3):245-9. PubMed ID: 17707724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2004 Dec; 70(6):498-505. PubMed ID: 15541413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymer-based nanocarriers for vaginal drug delivery.
    das Neves J; Nunes R; Machado A; Sarmento B
    Adv Drug Deliv Rev; 2015 Sep; 92():53-70. PubMed ID: 25550217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Statement of the Polish Gynecological Society expert panel concerning application of Fluomizin].
    Polish Gynecological Society
    Ginekol Pol; 2013 Mar; 84(3):237-9. PubMed ID: 23700855
    [No Abstract]   [Full Text] [Related]  

  • 59. [The use of eubiotics for the treatment of bacterial vaginosis].
    Kira EF; Kocherovets VI; Pospelova VV; Khanina GI
    Antibiot Khimioter; 1994; 39(2-3):31-5. PubMed ID: 7979792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relief of vaginal discomfort - hormones or water?
    Thompson E
    Climacteric; 2011 Jun; 14(3):398-9; author reply 399. PubMed ID: 21563997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.